{
    "id": 891,
    "fullName": "RAF1 E478K",
    "impact": "missense",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "RAF1 E478K lies within the protein kinase domain of the Raf1 protein (UniProt.org). E478K is not transforming in cell culture on its own (PMID: 16266992), but confers a gain of function to the Raf1 protein as demonstrated by increased Raf kinase activity (PMID: 23737487, PMID: 27273450) and is further increased in the context of oncogenic Ras (PMID: 16266992).",
            "references": [
                {
                    "id": 3186,
                    "pubMedId": 23737487,
                    "title": "C-RAF mutations confer resistance to RAF inhibitors.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/23737487"
                },
                {
                    "id": 9188,
                    "pubMedId": 27273450,
                    "title": "CRAF R391W is a melanoma driver oncogene.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/27273450"
                },
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 3188,
                    "pubMedId": 16266992,
                    "title": "Mutations of C-RAF are rare in human cancer because C-RAF has a low basal kinase activity compared with B-RAF.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/16266992"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 5894,
        "geneSymbol": "RAF1",
        "terms": [
            "RAF1",
            "c-Raf",
            "CMD1NN",
            "CRAF",
            "NS5",
            "Raf-1"
        ]
    },
    "variant": "E478K",
    "createDate": "07/03/2014",
    "updateDate": "02/20/2020",
    "referenceTranscriptCoordinates": {
        "id": 161723,
        "transcript": "NM_002880",
        "gDna": "chr3:g.12585785C>T",
        "cDna": "c.1432G>A",
        "protein": "p.E478K",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 6598,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, LY3009120 inhibited Raf dimer formation and downstream MAPK signaling in transformed cells expressing BRAF E586K and RAF1 E478K in culture (PMID: 26343583).",
            "molecularProfile": {
                "id": 23643,
                "profileName": "BRAF E586K RAF1 E478K"
            },
            "therapy": {
                "id": 3268,
                "therapyName": "LY3009120",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "predicted - sensitive",
            "references": [
                {
                    "id": 5709,
                    "pubMedId": 26343583,
                    "title": "Inhibition of RAF Isoforms and Active Dimers by LY3009120 Leads to Anti-tumor Activities in RAS or BRAF Mutant Cancers.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26343583"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        },
        {
            "id": 6599,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, transformed cells expressing BRAF E586K and RAF1 E478K in culture were insensitive to Zelboraf (vemurafenib) mediated inhibition of Raf signaling in culture (PMID: 26343583).",
            "molecularProfile": {
                "id": 23643,
                "profileName": "BRAF E586K RAF1 E478K"
            },
            "therapy": {
                "id": 342,
                "therapyName": "Vemurafenib",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "predicted - resistant",
            "references": [
                {
                    "id": 5709,
                    "pubMedId": 26343583,
                    "title": "Inhibition of RAF Isoforms and Active Dimers by LY3009120 Leads to Anti-tumor Activities in RAS or BRAF Mutant Cancers.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/26343583"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 8542,
            "profileName": "RAF1 E478K",
            "profileTreatmentApproaches": [
                {
                    "id": 5998,
                    "name": "Trametinib",
                    "profileName": "RAF1 E478K"
                },
                {
                    "id": 5927,
                    "name": "RAF Inhibitor (Pan)",
                    "profileName": "RAF1 E478K"
                }
            ]
        },
        {
            "id": 23643,
            "profileName": "BRAF E586K RAF1 E478K",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 161723,
            "transcript": "NM_002880",
            "gDna": "chr3:g.12585785C>T",
            "cDna": "c.1432G>A",
            "protein": "p.E478K",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 161724,
            "transcript": "XM_011533974",
            "gDna": "chr3:g.12585785C>T",
            "cDna": "c.1432G>A",
            "protein": "p.E478K",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 161725,
            "transcript": "XM_005265355",
            "gDna": "chr3:g.12585785C>T",
            "cDna": "c.1432G>A",
            "protein": "p.E478K",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}